Beth Sandy, MSN, CRNP, discusses the application of 2 FDA approved drugs for patients with non–small cell lung cancer and an exon 20 insertion mutation.
Beth Sandy, MSN, CRNP
Advertisement
Articles by Beth Sandy, MSN, CRNP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care
2
FDA Approves Rusfertide, First-in-Class Hepcidin Mimetic for Polycythemia Vera
3
Oncology Nurses' Guide to FDA-Approved Iberdomide: Q&A With Surbhi Sidana
4
FDA Approves BESREMi for Adults with Essential Thrombocythemia
5